Particle.news

HHS Announces Millions for AI Tools and Two Improved Lyme Diagnostics

HHS is using AI investments plus newly FDA‑cleared tests to speed diagnosis, improve care, support a 25% Lyme reduction goal by 2035.

Overview

  • HHS announced the actions Monday, saying it will invest millions to develop AI‑enabled tools meant to speed diagnosis, guide care and bolster research into Lyme and other tick‑borne diseases.
  • The department said it worked with the LymeX community to help bring two improved, FDA‑cleared Lyme diagnostics to market to give clinicians better tools for earlier and more accurate diagnosis.
  • LymeX Innovation Accelerator will continue running competitive challenges and has signaled planned awards of up to $2.5 million to spur new diagnostics and related innovations.
  • Actor Dennis Quaid joined Secretary Robert F. Kennedy Jr. in an HHS video to raise awareness and related a reported personal account about Kris Kristofferson’s 2016 Lyme diagnosis that has not been independently verified in news coverage.
  • Kennedy has framed the initiative around a policy goal to cut Lyme cases 25% by 2035 and cited NIH investments of about $50 million for Lyme research and $122 million for broader tick‑borne work as the funding backbone.